NICE - Endorsed Clinical Guidelines 2008/2009

Endorsed Clinical Guidelines 2008/2009

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG22 - Anxiety (amended) - HSC (SQSD) (NICE CG22) 24/2008

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG23 - Depression (amended)

• This guidance has been replaced by NICE CG90 - Treatment and management of depression in adults (update) problems, which was endorsed by the DoH in September 2010 - HSC (SQSD) (NICE CG90) 08/2010

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG41 - Familial breast cancer - HSC (SQSD) (NICE CG41) 41/2008​

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG43 - Obesity - HSC (SQSD) (NICE CG43) 58/2008 Note this guidance has been updated and replaced by NG246 - Overweight and obesity management, endorsed by the DoH in June 2025 

• Section 1.1.7 in this guideline has been updated and replaced by NICE PH53 which was endorsed by DoH in September 2016

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG45 - Antenatal and postnatal mental health

• This guidance has been updated and replaced by NICE CG192 - Antenatal and postnatal mental health: clinical management and service guidance which was endorsed by the DoH in February 2015 - HSC (SQSD) (NICE CG192) 9/2015

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG48 - MI: secondary prevention

• This guidance has been updated and replaced by NICE CG172 - Myocardial Infarction Secondary Prevention, which was endorsed by the DoH in January 2014 - HSC (SQSD) (NICE CG172) 1/2014

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG51 - Drug misuse: psychosocial interventions - HSC (SQSD) (NICE CG51) 59/2008

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG52 - Drug misuse: opioid detoxification - HSC (SQSD) (NICE CG52) 60/2008

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG55 - Intrapartum care

• This guidance has been updated and replaced by NICE CG190 - Intrapartum care: care of healthy women and their babies during childbirth, which was endorsed by the DoH in January 2015 - HSC (SQSD) (NICE CG190) 4/2015

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG56 - Head injury

• This guidance has been updated and replaced by NICE CG176 - Head injury: Triage, assessment, investigation and early management of head injury in children, young people and adults, which was endorsed by the DoH in March 2014 - HSC (SQSD) (NICE CG176) 6/2014

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG57 - Atopic eczema in children - HSC (SQSD) (NICE CG57) 34/2008

• Note this guidance has been partially updated by NG190 - Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing, which was endorsed by the DoH in March 2021.

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG58 - Prostate cancer: diagnosis and treatment

• This guidance has been updated and replaced by NICE Clinical Guideline NG131 - Prostate cancer: diagnosis and management, which was endorsed by the DoH in July 2019.

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG59 - Osteoarthritis: The care and management of osteoarthritis in adults

• This guidance has been updated and replaced by NICE CG177 - The care and management of osteoarthritis in adults, which was endorsed by the DoH in April 2014 - HSC (SQSD) (NICE CG 177) 8/2014

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG60 - Surgical management of children with otitis media effusion - HSC (SQSD) (NICE CG60) 07/2009

• Note this guidance has been updated and replaced by NG233 - Otitis media with effusion in under 12s, endorsed by the DoH in January 2024.

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG61 - Irritable bowel syndrome in adults

• Addendum added by NICE in February 2015, endorsed by the DoH in May 2015 - HSC (SQSD) (NICE CG61)16/2015

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG62 - Antenatal care

• ‘Note this guidance has been updated and replaced by NICE Clinical Guideline NG201 - Antenatal care, which was endorsed by the DoH in January 2022’.
• Note section 1.5.6 in this guideline has been updated and replaced by NICE CG 192 which was endorsed by DoH in February 2015 - HSC (SQSD) (NICE CG62) 55/2008
• Note section 1.3.2.4 in this guideline has been updated and replaced by NICE PH56 which was endorsed by DoH in April 2016.

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG63 - Diabetes in pregnancy: management of diabetes and its complications from pre-conception to postnatal period.

• This guidance has been updated and replaced by NICE NG3 - Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period which was endorsed by the DoH in May 2015 - HSC (SQSD) (NICE NG3) 17/2015

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG64 - Antibiotic prophylaxis against infective endocarditis - HSC (SQSD) (NICE CG64) 46/2008

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG65 - Management of inadvertent perioperative hypothermia in adults - HSC (SQSD) (NICE CG65) 13/2009

• This guidance has been updated and replaced by NICE CG65 - Hypothermia: Prevention and Management in Adults Having Surgery - Addendum which was endorsed by the DoH in February 2017 - HSC (SQSD) (NICE CG65) 11/2017

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG66 - Type 2 diabetes -the management of type 2 diabetes (update)

• This guidance has been updated and replaced by NICE NG28 - Type 2 diabetes in adults: management, which was endorsed by the DoH in February 2016 - HSC (SQSD) (NICE NG28) 08/2016

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG67 - Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

• This guidance has been updated and replaced by NICE CG181 - Lipid Modification, which was endorsed by the DoH in September 2014 - HSC (SQSD) (NICE CG181) 22/2014

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG72 - Attention deficit hyperactivity disorder - HSC (SQSD) (NICE CG72) 18/2009

• Addendum added by NICE in February 2016, endorsed by the DoH in April 2016 - HSC (SQSD) (NICE CG72) 20/16
• This guidance and the Addendum has been updated and replaced by NICE Clinical Guideline NG87 - Attention deficit hyperactivity disorder: diagnosis and management, which was endorsed by the DoH in May 2018.

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG73 - Chronic kidney disease - HSC (SQSD) (NICE CG73) 19/2009

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG74 - Surgical site infection - HSC (SQSD) (NICE CG74) 20/2009

• This guidance has been updated and replaced by NICE Clinical Guideline NG125 - Surgical site infections: prevention and treatment, which was endorsed by the DoH in June 2019.